Radiation therapy for gastric cancer bleeding.

Area of Science:

• Oncology
• Radiotherapy
• Gastroenterology

Background:

• Gastric cancer bleeding poses a significant challenge in palliative care.
• Limited treatment options exist for managing bleeding when other modalities are not feasible.

Purpose of the Study:

• To evaluate the effectiveness of palliative radiotherapy (RT) in managing gastric cancer bleeding.
• To assess both subjective and objective outcomes of RT for gastric cancer bleeding.

Main Methods:

• Retrospective review of 30 patients with gastric cancer bleeding treated with palliative RT.
• Analysis of 23 eligible patients receiving >= 30 Gy in 10 fractions.
• Evaluation of subjective symptom relief and objective markers like packed red blood cell (PRBC) transfusions and hemoglobin (Hb) levels before and after RT.

Main Results:

• 91% of patients experienced symptomatic relief from bleeding.
• Median PRBC transfusions decreased from 6 to 0 units per month post-RT (P < 0.001).
• Mean Hb levels increased significantly from 9.1 g/dL to 10.6 g/dL post-RT (P < 0.001).

Conclusions:

• Palliative radiotherapy is an effective treatment for gastric cancer bleeding.
• RT offers symptomatic palliation, improved Hb levels, and reduced transfusion requirements.
• This approach is particularly valuable when other interventions are not suitable.